Biomerica, Inc. (BMRA)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.0500 |
| Open | 1.0300 |
| Bid | 1.0500 x 1000 |
| Ask | 1.0600 x 800 |
| Day's Range | 1.0300 - 1.0816 |
| 52 Week Range | 1.0000 - 5.2500 |
| Volume | |
| Avg. Volume | 229,583 |
| Market Cap | 17.663M |
| Beta (5Y Monthly) | -0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4700 |
| Earnings Date | Oct 11, 2023 - Oct 16, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for BMRA
Related Research
- Biomerica, Inc.Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, global EV adoption rate to rise; patience will be rewarded for U.S. REIT investors; key takeaways from renewable energy conference; and Fortrea Holdings, Apple, and Bristol-Myers Squibb.RatingFair ValueEconomic Moat7 days agoMorningstar
GlobeNewswireMaxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.
NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Virtual Tech Conference Series: Emerging Growth in A.I. The conference will take place on Tuesday, September 26th, & Wednesday, September 27th, 2023, starting at 8:00 a.m. ET. We will be presenting our Virtual Tech Conference Series: Emerging Growth in A.I. The continu
GlobeNewswireDiagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian BioscienceAs CEO Kenny managed the sale of Meridian Biosciences in an all-cash transaction valued at approximately $1.53 billion NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today
Simply Wall St.Biomerica Full Year 2023 Earnings: US$0.50 loss per share (vs US$0.36 loss in FY 2022)
Biomerica ( NASDAQ:BMRA ) Full Year 2023 Results Key Financial Results Revenue: US$5.34m (down 72% from FY 2022). Net...
